EPIC PHARMA LLC FDA Approval ANDA 210532

ANDA 210532

EPIC PHARMA LLC

FDA Drug Application

Application #210532

Application Sponsors

ANDA 210532EPIC PHARMA LLC

Marketing Status

Prescription001

Application Products

001POWDER;TOPICAL100,000 UNITS/GM0NYSTATINNYSTATIN

FDA Submissions

UNKNOWN; ORIG1AP2018-04-30STANDARD

Submissions Property Types

ORIG1Null7

TE Codes

001PrescriptionAT

CDER Filings

EPIC PHARMA LLC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 210532
            [companyName] => EPIC PHARMA LLC
            [docInserts] => ["",""]
            [products] => [{"drugName":"NYSTATIN","activeIngredients":"NYSTATIN","strength":"100,000 UNITS\/GM","dosageForm":"POWDER;TOPICAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"04\/30\/2018","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2018-04-30
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.